Crowdonomics
WatchlistPortfolio
All companies

VIRONIX HEALTH INC.

Operating

Vironix Health Inc.

Healthcare · Founded 2020

Visit website

AI-enabled early detection and remote monitoring of lung and heart disease

Post-money valuation ⓘ
$12.1M
As of Apr 2023 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$4,128,720
Crowd $908K · Private $3.2M · 6 rounds since 2020
Latest share price
$10.66
Reg CF · Preferred Stock · Apr 2022 offering price · down round

Financials

FY2020–FY2024 · from SEC filings · hover any figure for its source
$0
−$25K
2020
2021
$2K
−$141K
2022
$57
−$302K
2023
$2K
−$792K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 reviewed
FY2021 reviewed
FY2022 unaudited
FY2023 unaudited
FY2024
Income statement
Revenue
$0
—
$2,408
$57
$2,325
Cost of goods sold
$0
—
$0
$0
$0
Gross margin
—
—
100%
100%
100%
Net income
-$24,539
—
-$141,223
-$302,311
-$792,139
Taxes paid
$0
—
$0
$0
$1,181
Balance sheet
Cash
$208,912
—
$103,621
$709,378
$842,883
Accounts receivable
$0
—
$0
$0
$0
Total assets
$224,843
—
$234,886
$1,190,951
$1,424,170
Short-term debt
$23,370
—
$10,910
$31,476
$37,841
Long-term debt
$226,000
—
$289,726
$0
$0
Total liabilities
$249,370
—
$300,636
$31,476
$37,841
Other
Headcount
—
3
—
6
6

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$11.2M
pre-money
Reg CF · Preferred · Apr 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

log scale
$30,666.7778$571.7586$10.66
Apr 2022Apr 2022
Round offering price or verified disclosed saleDisclosed sale, unverified or year-onlyDown round · Apr 2022 (-100%)

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Cap table

Principal holders% as the filing states it, Apr 30, 2024

  • Sumanth Swaminathan350,000 Class A Founder's Stock—of votes
  • Sumanth Swaminathan378,000 Common Stock—of votes

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Rule 506(b) · Convertible Note · Oct 2024Open
Raised $1.8MInvestors 14
Rule 506(b) · Convertible Note · May 2023Closed
Raised $1.2MInvestors 35
Reg CF · Preferred Stock · Apr 2022Closedvia WeFunder
Raised $907.7K / $1.1MInvestors 173Post-money $12.1M
Rule 506(c) · Equity · Apr 2022Closed
Raised $276KInvestors 9
Rule 506(c) · SAFE · Oct 2021Closed
Raised —

Team

1 person
Sumanth Swaminathan, PhDFounder
CoFounder & CEO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 2 of 4 annual reports (FY2022–FY2025)

173 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

View all 18 filings on EDGAR
  • Form D/ADec 29, 20250001833036-25-000004
    EDGAR
  • Form D/AAug 8, 20250001833036-25-000002
    EDGAR
  • Form D/ADec 30, 20240001833036-24-000004
    EDGAR
  • Form D/ADec 27, 20240001833036-24-000003
    EDGAR
  • Form D/AOct 30, 20240001833036-24-000001
    EDGAR
  • Form DOct 30, 20240001833036-24-000002
    EDGAR
  • Form C-ARApr 30, 20240001779318-24-000003
    EDGAR
  • Form DMay 31, 20230001833036-23-000005
    EDGAR
Source: ManualCIK 0001833036Share price $10.66

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.